The cellular response to aggregated proteins associated with human disease

Journal of Clinical Investigation

Volumn 110, Issue 9, 2002, Pages 1219-1220

  Perlmutter, David H ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLOID PRECURSOR PROTEIN; GENE PRODUCT; MUTANT PROTEIN; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALZHEIMER DISEASE; AUTOPHAGY; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL ORGANELLE; CELL TYPE; CYTOPATHOLOGY; DEGENERATIVE DISEASE; DEMENTIA; ENDOPLASMIC RETICULUM; GENE MUTATION; HUMAN; ISCHEMIA; NERVE CELL LESION; NERVE DEGENERATION; ONSET AGE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS; UPREGULATION;

ALPHA 1-ANTITRYPSIN DEFICIENCY; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CYSTIC FIBROSIS; ENDOPLASMIC RETICULUM; HUMANS; MUTATION; PROTEIN FOLDING;

EID: 0036840193     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200216780     Document Type: Short Survey

References (15)

1. Anfinsen, C.B. 1973. Principles that govern the folding of protein chains. Science. 181:223-230.
2. Horwich, A. 2002. Protein aggregation in disease: A role of folding intermediates forming specific multimeric interactions. J. Clin. Invest. 110:1221-1232. doi: 10.1172/JCI200216781.
3. Bucciantini, M., et al. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
4. Selkoe, D.J. 2002. Deciphering the genesis and fate of amyloid-β protein yields novel therapies for Alzheimer disease. J. Clin. Invest. In press.
5. Walsh, D.M., et al. 2002. Naturally secreted oligomers of amyloid? Protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:535-539.
6. Fewell, S.W., Travers, K.J., Weissman J.S., and Brodsky, J.L. 2001. The action of molecular chaperones in the early secretory pathway. Annu. Rev. Genet. 35:149-191.
7. Mayer, T., Braun, T., and Jentsch, S. 1998. Role of the proteosome in membrane extraction of a shortlived ER-transmembrane protein. EMBO J. 17:3251-3257.
8. Kaufman, R. 2002. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. In press.
9. Ron, D. 2002. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. In press.
10. Oyadomari, S., et al. 2002. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109:525-532. doi:10.1172/JCI200214550.
11. Gelman, M.S., and Kopito, R.R. 2002. Rescuing protein conformation: Prospects for pharmacological therapy in cystic fibrosis. J. Clin. Invest. In press.
12. Lomas, D.A., and Mahadeva, R. 2002. α1-antitrypsin polymerization and the serpinopath: Pathobiology and prospects for therapy. J. Clin. Invest. In press.
13. Davis, R.L., et al. 1999. Familial dementia caused by polymerization of mutant neuroserpin. Nature. 401:376-379.
14. Perlmutter, D.H. 2002. Liver injury in α1-antitrypsin deficiency: Role of autophagy and mitochondrial injury in response to aggregated protein in the endoplasmic reticulum. J. Clin. Invest. In press.
15. Dickson, K.M., et al. 2002. Association ofcalnexin with mutant peripheral myelin protein-22 ex vivo: A basis for "gain-of-function" ER diseases. Proc. Natl. Acad. Sci. USA. 99:9852-9857.